Mirtazapine - A multifunctional drug: Low dose for akathisia

CNS Spectrums

Volumn 16, Issue 2, 2011, Pages

  Poyurovsky, Michael ^a   Weizman, Ronit ^b   Weizman, Abraham ^c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV COMMUNITY MENTAL HEALTH CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; CYPROHEPTADINE; MIANSERIN; MIRTAZAPINE; PROPRANOLOL; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AKATHISIA; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DYSTONIA; GOLD STANDARD; HUMAN; LETTER; LOW DRUG DOSE; PARKINSONISM; PRIORITY JOURNAL; TREATMENT PLANNING; RESTLESSNESS;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; PSYCHOMOTOR AGITATION;

EID: 79953006815     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852912000181     Document Type: Letter

References (9)

1. Stahl SM. Multifunctional Drugs. A Novel Concept for Psychopharmacology. CNS Spectr. 2009;14(2):71-73.
2. Van der Schyf CJ, Youdim MB. Multifunctional drugs as neurotherapeutics. Neurotherapeutics. 2009;6(1):1-3.
3. Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr. 2009;14(10):536-346.
4. Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. J Pharmacol Exp Ther. 1989;251(1):238-246.
5. Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biol Psychiatry. 2006;59(11):1071-1077.
6. Poyurovsky M, Weizman A Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia. Int Clin Psychopharmacol. 1999;14(6):357-360.
7. Gulsun M, Doruk A. Mirtazapine-induced akathisia. J Clin Psychopharmacol. 2008; 28(4):467.
8. Stryjer R, Strous RD, Bar F, et al. Treatment of neuroleptic-induced akathisia with the 5-HT2A antagonist trazodone. Clin Neuropharmacol. 2003;26(3):137-141.
9. Hieber R, Dellenbaugh T, Nelson LA. Role of mirtazapine in the treatment of antipsychotic-induced akathisia. Ann Pharmacother. 2008;42(6):841-846.